Project Name: Beatson West of Scotland Cancer Centre Patient Support Videos
Project Summary:
The Beatson West of Scotland Cancer Centre (BWoSCC or “Beatson) is the largest Specialised Cancer Centre in Scotland. It provides a “hub and spoke” model for a population which covers 2.9 million, over four Health Boards: NHS Greater Glasgow & Clyde (NHS GGC), NHS Lanarkshire, NHS Ayrshire and Arran and NHS Forth Valley. An internationally renowned teaching centre, the Cancer Centre incorporates the academic units of Medical Oncology, Radiation Oncology, Translational Research and Palliative Care. The centre treats over 10,000 new patients and over 70,000 returning patients annually. Each year , more than100,000 fractions of radiotherapy and 28,000 cycles of chemotherapy are administered within the centre. Traditionally the clinical teams also deliver medical cancer treatments in 13 local hospitals in collaboration with local specialist cancer teams.
The Collaborative Working Project (CWP) with the Beaston West of Scotland Cancer Centre at NHS Greater Glasgow and Clyde (NHS GGC) aims to develop 6-7 informative oncology related patient videos to enable the following aims:
- Manage patient and care giver expectations of potential oncology treatments and /or procedures and in turn provide increased patient empowerment;
- Address service capacity levels by alleviating time pressures on oncology healthcare professionals whereby time is spent repeating similar patient queries on a daily basis;
- Monitor patient and service impact.
- Share insights and best practice at a national level. (Clinical Audit and Research meeting Scottish BC Annual meeting 2025- managed by MCN) UK BC Group Meeting.)
Novartis will have the option to utilise the patient education videos within a patient support programme if needed.
Planned Milestones:
| Milestone | Description |
|---|---|
| 1 | Project Kick off meeting with Clinical, service and Medical Illustration Team |
| 2 | Ratification of the titles and useful content of the patient videos by the patient advisory group |
| 3 | Baseline information of patient satisfaction survey |
| 4 | Draft Scripts and storyboard completed for patient videos |
| 5 | Draft storyboards reviewed by a number of patients |
| 6 | Alignment meetings up to x3 between NHS and Novartis medical approval teams to finalise drafts before approval |
| 7 | Scripts and storyboard approved by medical illustrations and communications teams. At this point the script will be sent for learning to the actor. |
| 8 | Scripts approved by Novartis legal/medical review |
| 9 | Medical Illustrations videos completed filming |
| 10 | Medical illustration editing |
| 11 | Share videos with patient group that was involved in the titles generation |
| 12 | QR codes started distribution for the videos to be accessed via medical notes/emails and small cards |
| 13 | Complete 3 months data on outcomes table |
| 14 | Evaluate 6 months patient video from Beatson web page analytics of satisfaction star rating |
| 15 | Present outcomes of project at national level |
| 16 | Analysis of CWP data and Submission of Outcomes Summary |
Expected Benefits:
Anticipated Benefits for Patients
- Increase in patient knowledge in digestible accessible format through video, that can be repeated individually and/or with patient support network.
- Increase in patient confidence in managing expectations about potential treatment and/or diagnostics.
- Ability to increase patient empowerment, alleviating queries and potentially reducing the need to contact HCPs as frequently
Anticipated Benefits for The Organisation
- Release capacity constraints through reducing the HCP time addressing similar patient queries several times a day.
- Standardising consistency of patient messages via equitable method of communication.
- Continuing to deliver optimised patient care and treatment levels through utilising media and IT to address patient needs
Anticipated Benefits for Novartis
- Opportunity to provide patient video education on SACT therapy
- Ethical, professional, and transparent relationship between Novartis and the Healthcare Organisations
- Enhanced reputation, and supporting Novartis’ vision that no patient should have to wait for an extraordinary life, by supporting high quality Collaborative Working with healthcare organisations which addresses the problem of health inequalities
Start Date & Duration: December 2024 for 20 months
FA-11306852